- Home
- Supplements
- Resveratrol
- Antioxidant Protection
Resveratrol for Antioxidant Protection
Antioxidant biomarker changes are inconsistent across human studies.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 150-1,000 mg/day trans-resveratrol with food; antioxidant marker changes in humans are inconsistent
- Expected timeframe
- 8-12 weeks
Protocol
- form
- Trans-resveratrol; bioavailability is under 1%, and micronised or piperine-combined forms improve absorption modestly
- duration
- 8-12 weeks
- co factor
- Take with food containing fat. Evidence is mixed. Resveratrol is a potent antioxidant in vitro and induces Nrf2-mediated antioxidant enzyme expression, and some human trials report reduced oxidative stress markers - lower F2-isoprostanes, oxidised LDL or malondialdehyde - particularly in people with type 2 diabetes, metabolic syndrome or obesity. Trials in healthy adults generally show nothing. Bioavailability under 1% and rapid conjugation to glucuronide and sulfate metabolites with different activity explain much of the gap between laboratory potency and human results. Antioxidant marker change is also not a clinical outcome.
- titration
- Up to 500 mg/day; 1,000 mg/day is the practical ceiling before gastrointestinal effects predominate
- starting dose
- 150 mg/day of trans-resveratrol with a fat-containing meal
Evidence
What the studies say
A review of pterostilbene antioxidant activity and disease modification
McCormack D, McFadden D
Preclinical work shows antioxidant, anti-inflammatory and metabolic effects of pterostilbene, with greater bioavailability than resveratrol.
Safety
Caveats
In vitro antioxidant potency has a poor record of predicting human benefit - beta-carotene, vitamin E and vitamin C supplementation showed no benefit and in some cases harm in large trials. More specifically here, two controlled trials found resveratrol blunted the training-induced improvements in blood pressure, lipids and aerobic capacity in older and younger men, consistent with the broader finding that high-dose antioxidants can interfere with exercise adaptation - so if you train, this is a reason to avoid it. Safety of resveratrol: up to 1,000 mg/day is tolerated short term, gastrointestinal effects become common above that, and a myeloma trial at 5 g/day was terminated after renal failure cases. It inhibits CYP3A4, CYP2C9 and CYP1A2, raising levels of many drugs including statins, calcium channel blockers and ciclosporin, and has antiplatelet activity - avoid with warfarin, direct oral anticoagulants, aspirin and antiplatelet drugs, and stop two weeks before surgery. Oestrogenic activity means caution with hormone-sensitive cancer. Avoid in pregnancy and breastfeeding. A diet rich in vegetables, fruit, nuts and whole grains has the evidence isolated antioxidants lack.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.